Publication: RNA aptamers selected against yeast cells inhibit Candida albicans biofilm formation in vitro
2
Issued Date
2019-01-01
Resource Type
ISSN
20458827
DOI
Other identifier(s)
2-s2.0-85070626516
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
MicrobiologyOpen. Vol.8, No.8 (2019)
Suggested Citation
Boy M. Bachtiar, Chatchawan Srisawat, Endang W. Bachtiar RNA aptamers selected against yeast cells inhibit Candida albicans biofilm formation in vitro. MicrobiologyOpen. Vol.8, No.8 (2019). doi:10.1002/mbo3.812 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/51123
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
RNA aptamers selected against yeast cells inhibit Candida albicans biofilm formation in vitro
Other Contributor(s)
Abstract
© 2019 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. Aptamers that bind live bacterial cells have been widely investigated, but their potential to inhibit Candida albicans biofilm formation needs to be further explored. The aims of this study were to evaluate the binding of C. albicans to RNA aptamers and to examine the potential of aptamers to inhibit C. albicans biofilm formation in vitro. In this study, RNA aptamers selected against yeast cells of C. albicans ATCC 10231 were developed using the systematic evolution of ligands by exponential enrichment (SELEX) technique. The binding affinity of the resulting aptamers was then determined by an aptamer-linked immobilized sorbent assay (ALISA), and a colorimetric (MTT) assay was used to measure the metabolic activity of Candida biofilms. After 11 rounds of SELEX, two candidate aptamers, Ca-apt-1 and Ca-apt-12, were identified. The Ca-apt-1 aptamer also recognized C. albicans isolated from clinical specimens but did not recognize other oral microorganisms (i.e., Streptococcus mutans and Saccharomyces cerevisiae). The ALISA results showed that the binding affinity of these aptamers was comparable to that of an anti-C. albicans monoclonal antibody. In addition, Ca-apt-1 could inhibit biofilm and hyphal formation of C. albicans in vitro, as demonstrated using biofilm assays. This study shows that RNA aptamers could potentially be used in diagnostic and therapeutic applications for C. albicans-related disease in the future.